Iovance Biotherapeutics Inc (NASDAQ:IOVA) price closed higher on Friday, May 03, jumping 5.82% above its previous close.
A look at the daily price movement shows that the last close reads $12.88. Taking into account the 52-week price action we note that the stock hit a 52-week high of $18.33 and 52-week low of $3.21. The stock added 0.22% on its value in the past month.
Iovance Biotherapeutics Inc, which has a market valuation of $3.81 billion. Analysts tracking IOVA have forecast the quarterly EPS to shrink by -0.42 per share this quarter, while the same analysts predict the annual EPS to hit -$1.27 for the year 2024 and up to -$0.71 for 2025. In this case, analysts estimate an annual EPS growth of 32.80% for the year and 44.10% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $2.07 million, with the likely lows of $480k and highs of $6 million. The average estimate suggests sales growth for the quarter will likely rise by 935.00% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of $167.38 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow 13,977.40% above that which the company brought in 2024.
On the technical perspective front, indicators give IOVA a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
The overview shows that IOVA’s price is at present 11.79% off the SMA20 and -2.87% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 59.83, with weekly volatility standing at 5.99%. The indicator jumps to 5.34% when calculated based on the past 30 days. Iovance Biotherapeutics Inc (NASDAQ:IOVA)’s beta value is holding at 0.87, while the average true range (ATR) indicator is currently reading 0.77.
An analysis of the Iovance Biotherapeutics Inc (NASDAQ:IOVA) stock in terms of its daily trading volume indicates that the 3-month average is 8.92 million.
Current records show that the company has 256.14M in outstanding shares. The insiders’ percentage holdings are 20.98% of outstanding shares while the percentage share held by institutions stands at 66.27%. But the 67.65% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
